(Q53333322)

13 May 2018

title

Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy. (English)

1 reference

13 May 2018

recurrent endometrial cancer

main subject

1 reference

3

Jassem J

1 reference

13 May 2018

author name string

Jereczek-Fossa B

series ordinal

1

1 reference

13 May 2018

Badzio A

series ordinal

2

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

13 May 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

13 May 2018

volume

48

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

405-413

1 reference

13 May 2018

cites work

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Risk factors for recurrence in clinically early endometrial carcinoma: an analysis of 183 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Surgery followed by radiotherapy in endometrial cancer: analysis of survival and patterns of failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Endometrial carcinoma: does the addition of intracavitary vault caesium to external beam therapy postoperatively result in improved control or increased morbidity?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

An analysis of approaches to the treatment of endometrial cancer in Western Europe: A CTF study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

An Analysis of Approaches to the Management of Endometrial Cancer in North America: A CTF Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Isolated vaginal recurrences of endometrial adenocarcinoma and their management

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Results of radiotherapy in recurrent endometrial carcinoma: a retrospective analysis of 51 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

The salvage of recurrent endometrial carcinoma in the vagina and pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Prognostic factors related to recurrent endometrial carcinoma following initial surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Malignant tumors of the vagina

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Radiation Dose-Rate: A Factor of Importance in Radiobiology and Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

A new isoeffect curve for change in dose per fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Risk-specific follow-up for endometrial carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

How should we monitor women treated for endometrial carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Recurrent stage I endometrial carcinoma: results of treatment and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Vaginal recurrence of adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Postoperative radiation therapy for surgically staged endometrial cancer: impact of time factors (overall treatment time and surgery-to-radiation interval) on outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Endometrial carcinoma: high dose-rate brachytherapy in combination with external irradiation; a multivariate analysis of relapses

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Radiation Therapy as Exclusive Treatment for Medically Inoperable Patients with Stage I and II Endometrioid Carcinoma of the Endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Clinical stage I endometrial cancer: results of adjuvant irradiation and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Stage I, grade III adenocarcinoma of the endometrium treated with surgery and irradiation. Sites of failure and correlation of failure rate with irradiation technique

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Radiation sensitivity of endometrial carcinoma in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

Pattern of recurrences in endometrial carcinoma and their management

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900642-8

7 January 2021

10.1016/S0360-3016(00)00642-8

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018